- Report
- August 2023
- 80 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 70 Pages
North America
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 70 Pages
Asia Pacific
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 110 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 90 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- August 2023
- 110 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2023
- 115 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2023
- 110 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- October 2022
- 70 Pages
Africa
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2026
- 143 Pages
India
From €2247EUR$2,499USD£1,926GBP
€3596EUR$3,999USD£3,082GBP
- Report
- June 2025
- 400 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- July 2023
- 160 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- May 2023
- 160 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- December 2024
- 144 Pages
Global
From €13482EUR$14,995USD£11,558GBP
- Report
- November 2024
- 69 Pages
Global
From €3592EUR$3,995USD£3,079GBP
- Report
- May 2024
- 93 Pages
Global
From €13482EUR$14,995USD£11,558GBP
- Report
- November 2021
- 124 Pages
Global
From €13482EUR$14,995USD£11,558GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more